Therefore, in this study, we examine the premise that global genetic ablation of iNOS will delay or block draining LN expansion, maintain LV contractions, and lessen the severity of synovitis and erosions in a murine RA model. The gene discussed is NOS2; the disease is rheumatoid arthritis.